Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-02-27 |
2023-12 |
-0.29 |
N/A |
N/A |
N/A |
2023-11-08 |
2023-09 |
-0.3 |
N/A |
N/A |
N/A |
2023-08-08 |
2023-06 |
-0.37 |
N/A |
N/A |
N/A |
2023-05-09 |
2023-03 |
-0.41 |
N/A |
N/A |
N/A |
2023-02-28 |
2022-12 |
-0.55 |
N/A |
N/A |
N/A |
2022-11-08 |
2022-09 |
-0.59 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-10-19 |
Goldman Sachs |
Upgrade |
Sell |
Sell |
2023-08-14 |
Piper Sandler |
Upgrade |
Underweight |
Underweight |
2023-07-23 |
Goldman Sachs |
Upgrade |
Sell |
Sell |
2023-07-20 |
Goldman Sachs |
Upgrade |
Sell |
Sell |
2023-05-14 |
Raymond James |
Downgrade |
Market Perform |
Underperform |
2023-05-10 |
Goldman Sachs |
Upgrade |
Sell |
Sell |
Date |
Name |
Relation |
Quantity |
Description |
2023-10-17 |
BRIDA THOMAS |
General Counsel |
933.59K |
Stock Award(Grant) |
2023-04-26 |
GORJANC CHRISTINE MARIE |
Director |
111.02K |
Stock Award(Grant) |
2023-09-21 |
GUIGLEY ROBERT M |
Officer |
850.00K |
Stock Award(Grant) |
2023-05-15 |
KNIGHT KENNETH D. |
Chief Executive Officer |
1.67M |
Sale |
2023-06-12 |
NUSSBAUM ROBERT L. |
Officer |
569.35K |
Sale |
2023-10-01 |
SCHRANK ANA J. |
Chief Financial Officer |
850.00K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-09-29 |
ARK Investment Management, LLC |
32.94M |
19.94M |
12.34% |
2023-06-29 |
Blackrock Inc. |
21.32M |
24.10M |
7.99% |
2023-06-29 |
Nikko Asset Management Americas, Inc. |
16.91M |
19.11M |
6.33% |
2023-06-29 |
Sumitomo Mitsui Trust Holdings, Inc. |
16.91M |
19.11M |
6.33% |
2023-06-29 |
Vanguard Group Inc |
13.17M |
14.89M |
4.93% |
2023-06-29 |
Baker Brothers Advisors, LLC |
8.88M |
10.04M |
3.33% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-09-29 |
ARK ETF Tr-ARK Innovation ETF |
18.88M |
11.43M |
7.07% |
2023-09-29 |
ARK ETF Tr-ARK Genomic Revolution ETF |
9.06M |
5.48M |
3.39% |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
7.45M |
8.42M |
2.79% |
2023-08-30 |
iShares Russell 2000 ETF |
6.11M |
5.64M |
2.29% |
2023-06-29 |
Vanguard Extended Market Index Fund |
3.14M |
3.55M |
1.18% |
2023-07-30 |
Fidelity Small Cap Index Fund |
2.35M |
3.34M |
0.88% |